STI-1558
- Generic Name
- STI-1558
A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2023-12-13
- Lead Sponsor
- Zhejiang ACEA Pharmaceutical Co. Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT06044233
- Locations
- 🇨🇳
Zhejiang Xiaoshan Hospital, Hangzhou, China
Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Zhejiang ACEA Pharmaceutical Co. Ltd.
- Target Recruit Count
- 1218
- Registration Number
- NCT05716425
- Locations
- 🇨🇳
Beijing Ditan Hospital, Capital Medical University, Beijing, China
🇨🇳Shenzhen Third People 's Hospital, Shenzhen, China
A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558
Phase 1
Completed
- Conditions
- COVID-19 Pneumonia
- Interventions
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- Zhejiang ACEA Pharmaceutical Co. Ltd.
- Target Recruit Count
- 37
- Registration Number
- NCT05685719
- Locations
- 🇨🇳
Zhejiang Xiaoshan Hospital, Hangzhou, Zhejiang, China
Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Zhejiang ACEA Pharmaceutical Co. Ltd.
- Target Recruit Count
- 79
- Registration Number
- NCT05523739
- Locations
- 🇨🇳
The Third People's Hospital Of Shenzhen, Shenzhen, Guangdong, China
Study to Assess the Safety, Tolerability and Pharmacokinetics of STI-1558 in Healthy Volunteers
- First Posted Date
- 2022-05-06
- Last Posted Date
- 2023-01-30
- Lead Sponsor
- Sorrento Therapeutics, Inc.
- Target Recruit Count
- 58
- Registration Number
- NCT05364840
- Locations
- 🇦🇺
Scientia Clinical Research Ltd, Randwick, New South Wales, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath